Bloodstream Infections in Intensive Care Unit during Four Consecutive SARS-CoV-2 Pandemic Waves.

COVID-19 bloodstream infection critically ill enterococcus pseudomonas

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
14 Sep 2023
Historique:
received: 21 08 2023
revised: 10 09 2023
accepted: 13 09 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Critically ill COVID-19 patients are at an increased risk of bloodstream infections (BSIs). We performed a retrospective observational single-center study on COVID-19 patients admitted to intensive care unit (ICU) to assess the incidence of BSIs in four consecutive periods: 21 February-31 July 2020 (W1), 1 August 2020-31 January 2021 (W2), 1 February-30 September 2021 (W3) and 1 October 2021 and 30 April 2022 (W4). BSIs that occurred 48 h after ICU admission were included. The crude incidence of BSIs was estimated by means of Poisson distribution normalized to 1000 patient-days. A total of 404 critically ill COVID-19 patients were admitted to ICU, of whom 284 (61%) developed at least one episode of BSI with an overall crude incidence of 87 events every 1000 patient-days (95% CI 77-98) without a significant difference in consecutive epidemic periods (

Identifiants

pubmed: 37760744
pii: antibiotics12091448
doi: 10.3390/antibiotics12091448
pmc: PMC10525187
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Hosp Infect. 2022 Jan;119:175-181
pubmed: 34547320
Pharmacol Res. 2021 Feb;164:105403
pubmed: 33359914
Am J Infect Control. 2022 Mar;50(3):245-249
pubmed: 34971717
Open Forum Infect Dis. 2023 Jul 26;10(7):ofad358
pubmed: 37520417
BMC Infect Dis. 2022 Nov 11;22(1):841
pubmed: 36368931
Crit Care Med. 2021 Jan 1;49(1):e31-e40
pubmed: 33122577
Clin Microbiol Infect. 2022 Apr;28(4):491-501
pubmed: 34843962
Emerg Infect Dis. 2022 Nov;28(11):2181-2189
pubmed: 36191608
Science. 2020 Jul 3;369(6499):50-54
pubmed: 32358202
Gastroenterology. 2020 May;158(6):1831-1833.e3
pubmed: 32142773
J Hosp Infect. 2022 Jan;119:149-154
pubmed: 34627934
Infection. 2003 Dec;31 Suppl 2:4-9
pubmed: 15018466
Mod Pathol. 2020 Nov;33(11):2128-2138
pubmed: 32572155
Antibiotics (Basel). 2021 Jan 29;10(2):
pubmed: 33573070
Nat Rev Microbiol. 2012 Mar 16;10(4):266-78
pubmed: 22421879
Sci Rep. 2021 Sep 22;11(1):18844
pubmed: 34552127
Chest. 2021 Aug;160(2):454-465
pubmed: 33857475
Crit Care. 2022 Oct 18;26(1):319
pubmed: 36258239
Surg Infect (Larchmt). 2009 Apr;10(2):137-42
pubmed: 19388836
Int Immunopharmacol. 2021 Jan;90:107225
pubmed: 33302033
Autoimmun Rev. 2020 Jul;19(7):102564
pubmed: 32376396
Ann Intensive Care. 2021 Dec 24;11(1):183
pubmed: 34952960
J Hosp Infect. 2004 Oct;58(2):137-45
pubmed: 15474185
Ann Med. 2021 Dec;53(1):1779-1786
pubmed: 34637370
Arch Pathol Lab Med. 2021 Sep 1;145(9):1062-1068
pubmed: 33961007
J Pathol. 2004 Jun;203(2):622-30
pubmed: 15141376
Signal Transduct Target Ther. 2022 May 3;7(1):146
pubmed: 35504917
Clin Infect Dis. 2021 Jun 15;72(12):e995-e1003
pubmed: 33216875
Clin Microbiol Infect. 2021 Mar;27(3):451-457
pubmed: 33223114
Infection. 2023 Feb;51(1):129-136
pubmed: 35687293
J Clin Med. 2021 Apr 17;10(8):
pubmed: 33920701
Intensive Care Med. 2021 Jan;47(1):60-73
pubmed: 33211135
Int J Infect Dis. 2022 Jan;114:90-96
pubmed: 34688945
Elife. 2022 Aug 02;11:
pubmed: 35916373
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Intensive Care Med. 2021 Feb;47(2):188-198
pubmed: 33388794
JAMA. 2020 Apr 28;323(16):1545-1546
pubmed: 32167538
Crit Care Med. 2022 May 1;50(5):825-836
pubmed: 35148524
J Glob Antimicrob Resist. 2020 Dec;23:290-291
pubmed: 33130024
Crit Care. 2016 Mar 09;20:53
pubmed: 26956367
PLoS One. 2023 Apr 28;18(4):e0281052
pubmed: 37115764
Infect Control Hosp Epidemiol. 2022 Oct;43(10):1416-1423
pubmed: 34486503
Clin Infect Dis. 2004 Aug 15;39(4):511-6
pubmed: 15356814
Crit Care. 2022 Jun 2;26(1):158
pubmed: 35655224
Cell Rep. 2021 Aug 31;36(9):109637
pubmed: 34433082
Antibiotics (Basel). 2021 Jun 25;10(7):
pubmed: 34202340
J Intensive Care Med. 2022 Oct;37(10):1353-1362
pubmed: 35607286
PLoS One. 2021 May 6;16(5):e0251170
pubmed: 33956882
Ann Med. 2022 Dec;54(1):524-540
pubmed: 35132910

Auteurs

Giacomo Pozza (G)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.
Department of Biomedical Sciences and Clinics, Università degli Studi di Milano, 20157 Milan, Italy.

Giacomo Casalini (G)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.
Department of Biomedical Sciences and Clinics, Università degli Studi di Milano, 20157 Milan, Italy.

Cosmin Lucian Ciubotariu (CL)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.
Department of Biomedical Sciences and Clinics, Università degli Studi di Milano, 20157 Milan, Italy.

Andrea Giacomelli (A)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.

Miriam Galimberti (M)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.
Department of Biomedical Sciences and Clinics, Università degli Studi di Milano, 20157 Milan, Italy.

Martina Zacheo (M)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.
Department of Biomedical Sciences and Clinics, Università degli Studi di Milano, 20157 Milan, Italy.

Andrea Rabbione (A)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.
Department of Biomedical Sciences and Clinics, Università degli Studi di Milano, 20157 Milan, Italy.

Margherita Pieruzzi (M)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.
Department of Biomedical Sciences and Clinics, Università degli Studi di Milano, 20157 Milan, Italy.

Letizia Oreni (L)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.

Laura Galimberti (L)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.

Riccardo Colombo (R)

Intensive Care Unit, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.

Giuliano Rizzardini (G)

I Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.

Cristina Pagani (C)

Clinical Microbiology, Virology and Bioemergency, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.

Sara Giordana Rimoldi (SG)

Clinical Microbiology, Virology and Bioemergency, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.

Cecilia Bonazzetti (C)

Infectious Diseases Unit IRCCS, Policlinico Sant'Orsola, Department Medical Surgical Science, University of Bologna, 40138 Bologna, Italy.

Anna Lisa Ridolfo (AL)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.

Spinello Antinori (S)

III Division of Infectious Diseases, Luigi Sacco Hospital, ASST Fatebenefratelli Sacco, 20157 Milan, Italy.
Department of Biomedical Sciences and Clinics, Università degli Studi di Milano, 20157 Milan, Italy.

Classifications MeSH